• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘油三酯-葡萄糖指数与2型糖尿病ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后的无复流现象相关。

The triglyceride-glucose index is associated with no-reflow phenomenon in STEMI patients with type 2 diabetes after percutaneous coronary intervention.

作者信息

Ma Juan, Wu Peng, Ma Shengzong, Ma Xueping, Jin Ping, Jia Shaobin

机构信息

School of Clinical Medicine, Ningxia Medical University, Yinchuan, China.

Department of Gynaecology and Obstetrics, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.

出版信息

Front Cardiovasc Med. 2024 Sep 12;11:1386318. doi: 10.3389/fcvm.2024.1386318. eCollection 2024.

DOI:10.3389/fcvm.2024.1386318
PMID:39346096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11428104/
Abstract

BACKGROUND

The relationship between the triglyceride-glucose (TyG) index and no-reflow phenomenon after percutaneous coronary intervention (PCI) in patients with type 2 diabetes mellitus (T2DM) and acute ST-segment elevation myocardial infarction (STEMI) remains unclear. This study aimed to investigate the relationship between baseline TyG index and no-reflow phenomenon in STEMI patients with T2DM after PCI.

METHODS

This study enrolled 695 patients with T2DM and STEMI from the General Hospital of Ningxia Medical University (2014-2019). Patients were divided into tertiles according to the TyG index levels. The incidence of no-reflow phenomenon was recorded. A multivariate regression model was developed to analyze the association between the baseline TyG index and no-reflow phenomenon. The linear association between the baseline TyG index and no-reflow phenomenon was explored using smooth curve fitting with parallel subgroup analyses. Receiver operating characteristic (ROC) curves were generated to determine the predictive power of the TyG index.

RESULTS

A multivariate logistic regression model revealed that the TyG index was an independent risk factor of no-reflow phenomenon [OR = 3.23, 95%CI: 2.15-4.86,  < 0.001], and the occurrence of no-reflow phenomenon increased gradually with the increase of TyG index tertile interval ( < 0.001). Smooth curve fitting showed that the TyG index was linearly related to the risk of no-reflow. Subgroup analysis showed that they participated in this positive correlation. The area under the ROC curve (AUC) of the TyG index for evaluating the occurrence of no-reflow was 0.710 (95% CI: 0.640-0.780; 0.01).

CONCLUSIONS

The TyG index is independently associated with no-reflow phenomenon, suggesting that the simple index of the TyG index can be used for risk assessment of no-reflow phenomenon after PCI in STEMI patients with T2DM.

摘要

背景

2型糖尿病(T2DM)合并急性ST段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入治疗(PCI)后,甘油三酯-葡萄糖(TyG)指数与无复流现象之间的关系尚不清楚。本研究旨在探讨T2DM合并STEMI患者PCI术后基线TyG指数与无复流现象之间的关系。

方法

本研究纳入了宁夏医科大学总医院695例T2DM合并STEMI患者(2014年至2019年)。根据TyG指数水平将患者分为三分位数。记录无复流现象的发生率。建立多因素回归模型分析基线TyG指数与无复流现象之间的关联。采用平滑曲线拟合和平行亚组分析探讨基线TyG指数与无复流现象之间的线性关联。绘制受试者工作特征(ROC)曲线以确定TyG指数的预测能力。

结果

多因素logistic回归模型显示,TyG指数是无复流现象的独立危险因素[比值比(OR)=3.23,95%置信区间(CI):2.15 - 4.86,P<0.001],且无复流现象的发生率随TyG指数三分位数区间的增加而逐渐升高(P<0.001)。平滑曲线拟合显示TyG指数与无复流风险呈线性相关。亚组分析显示各亚组均参与了这种正相关。TyG指数评估无复流发生情况的ROC曲线下面积(AUC)为0. -- 0.780;P<0.01)。

结论

TyG指数与无复流现象独立相关,提示TyG指数这一简单指标可用于T2DM合并STEMI患者PCI术后无复流现象的风险评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/382c/11428104/7d3c6bfe325e/fcvm-11-1386318-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/382c/11428104/832f1d2c4bec/fcvm-11-1386318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/382c/11428104/4382c8a873af/fcvm-11-1386318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/382c/11428104/04d04bbed323/fcvm-11-1386318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/382c/11428104/7d3c6bfe325e/fcvm-11-1386318-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/382c/11428104/832f1d2c4bec/fcvm-11-1386318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/382c/11428104/4382c8a873af/fcvm-11-1386318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/382c/11428104/04d04bbed323/fcvm-11-1386318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/382c/11428104/7d3c6bfe325e/fcvm-11-1386318-g004.jpg

相似文献

1
The triglyceride-glucose index is associated with no-reflow phenomenon in STEMI patients with type 2 diabetes after percutaneous coronary intervention.甘油三酯-葡萄糖指数与2型糖尿病ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后的无复流现象相关。
Front Cardiovasc Med. 2024 Sep 12;11:1386318. doi: 10.3389/fcvm.2024.1386318. eCollection 2024.
2
Predictive effect of triglyceride-glucose index on No-Reflow Phenomenon in patients with type 2 diabetes mellitus and acute myocardial infarction undergoing primary percutaneous coronary intervention.甘油三酯-葡萄糖指数对2型糖尿病合并急性心肌梗死患者行直接经皮冠状动脉介入治疗后无复流现象的预测作用。
Diabetol Metab Syndr. 2024 Mar 14;16(1):67. doi: 10.1186/s13098-024-01306-y.
3
Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.三酰甘油葡萄糖指数联合中性粒细胞与淋巴细胞比值对急性 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后主要不良心脏事件的预测价值。
Sci Rep. 2024 Jun 2;14(1):12634. doi: 10.1038/s41598-024-63604-9.
4
High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.高甘油三酯-葡萄糖指数与经皮冠状动脉介入治疗后急性 ST 段抬高型心肌梗死患者的预后不良相关。
Cardiovasc Diabetol. 2019 Nov 13;18(1):150. doi: 10.1186/s12933-019-0957-3.
5
The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes.胰岛素抵抗替代物对伴或不伴 2 型糖尿病的急性心肌梗死患者的预后影响。
Cardiovasc Diabetol. 2024 Apr 29;23(1):147. doi: 10.1186/s12933-024-02240-z.
6
Triglyceride-Glucose Index and New-Onset Atrial Fibrillation in ST-Segment Elevation Myocardial Infarction Patients After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后ST段抬高型心肌梗死患者的甘油三酯-葡萄糖指数与新发心房颤动
Front Cardiovasc Med. 2022 Mar 8;9:838761. doi: 10.3389/fcvm.2022.838761. eCollection 2022.
7
MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.MELD-XI 评分预测行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者无复流现象和短期死亡率。
BMC Cardiovasc Disord. 2022 Mar 18;22(1):113. doi: 10.1186/s12872-022-02556-2.
8
Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention.全身免疫炎症指数预测直接经皮冠状动脉介入治疗后无复流现象。
Acta Cardiol. 2022 Feb;77(1):59-65. doi: 10.1080/00015385.2021.1884786. Epub 2021 Feb 22.
9
A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.三酰甘油-葡萄糖指数与残余 SYNTAX 评分对行经皮冠状动脉介入治疗的 2 型糖尿病患者中期主要不良心脑血管事件的预测具有协同作用。
Cardiovasc Diabetol. 2022 Jun 24;21(1):115. doi: 10.1186/s12933-022-01553-1.
10
Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.甘油三酯葡萄糖指数联合斑块特征作为 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后心血管结局的新型生物标志物:一项血管内光学相干断层成像研究。
Cardiovasc Diabetol. 2021 Jun 28;20(1):131. doi: 10.1186/s12933-021-01321-7.

本文引用的文献

1
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes.GLP-1 受体激动剂- SGLT-2 抑制剂联合治疗与急性心肌梗死后心血管事件:2 型糖尿病患者的观察性研究。
Cardiovasc Diabetol. 2024 Jan 6;23(1):10. doi: 10.1186/s12933-023-02118-6.
2
The HbA1c/C-Peptide Ratio is Associated With the No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction.糖化血红蛋白与C肽比值与ST段抬高型心肌梗死患者的无复流现象相关。
Angiology. 2025 Mar;76(3):289-299. doi: 10.1177/00033197231213166. Epub 2023 Nov 3.
3
The stress hyperglycemic ratio can predict the no-reflow phenomenon following saphenous vein graft intervention in patients with acute coronary syndrome.
应激性高血糖比值可预测急性冠脉综合征患者行隐静脉旁路移植介入术后无复流现象。
Acta Diabetol. 2024 Mar;61(3):333-341. doi: 10.1007/s00592-023-02201-0. Epub 2023 Nov 2.
4
The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018.甘油三酯-葡萄糖指数是糖尿病或糖尿病前期心血管疾病患者心血管和全因死亡的预测指标:来自 NHANES 2001-2018 的证据。
Cardiovasc Diabetol. 2023 Oct 17;22(1):279. doi: 10.1186/s12933-023-02030-z.
5
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。
Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
6
Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study.基于人群的中老年人群肥胖和血脂相关指标与代谢综合征相关性的横断面研究。
Front Endocrinol (Lausanne). 2023 Jul 28;14:1201132. doi: 10.3389/fendo.2023.1201132. eCollection 2023.
7
SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis.钠-葡萄糖协同转运蛋白 2 抑制剂对伴有可诱导性心肌缺血和多支非阻塞性冠状动脉狭窄的糖尿病患者冠状动脉纤维帽厚度和主要不良心血管事件的影响。
Cardiovasc Diabetol. 2023 Apr 1;22(1):80. doi: 10.1186/s12933-023-01814-7.
8
Insulin resistance and cardiovascular disease.胰岛素抵抗与心血管疾病。
J Int Med Res. 2023 Mar;51(3):3000605231164548. doi: 10.1177/03000605231164548.
9
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes.钠-葡萄糖协同转运蛋白 2 抑制剂与急性心肌梗死后支架内再狭窄相关事件:2 型糖尿病患者的观察性研究。
BMC Med. 2023 Feb 24;21(1):71. doi: 10.1186/s12916-023-02781-2.
10
The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults.甘油三酯-葡萄糖指数作为代谢相关脂肪性肝病(MAFLD)的临床有用标志物:一项针对伊朗成年人的基于人群的研究。
J Diabetes Metab Disord. 2022 Jan 11;21(1):97-107. doi: 10.1007/s40200-021-00941-w. eCollection 2022 Jun.